Nutraceutical therapies for degenerative joint diseases: a critical review.
about
Caesalpinia sappan extract inhibits IL1β-mediated overexpression of matrix metalloproteinases in human chondrocytes.Phase 1, placebo-controlled, dose escalation trial of chicory root extract in patients with osteoarthritis of the hip or knee.Comparative therapeutic efficacy and safety of type-II collagen (UC-II), glucosamine and chondroitin in arthritic dogs: pain evaluation by ground force plate.Intra-articular injection of a nutritive mixture solution protects articular cartilage from osteoarthritic progression induced by anterior cruciate ligament transection in mature rabbits: a randomized controlled trialA longitudinal study of the association between dietary factors, serum lipids, and bone marrow lesions of the knee.Association of dietary magnesium intake with radiographic knee osteoarthritis: results from a population-based studyGlucose: an energy currency and structural precursor in articular cartilage and bone with emerging roles as an extracellular signaling molecule and metabolic regulator.Repression of calcitonin gene-related peptide expression in trigeminal neurons by a Theobroma cacao extract.Serum Calcium Concentration Is Inversely Associated With Radiographic Knee Osteoarthritis: A Cross-Sectional Study.Dietary fatty acid intake affects the risk of developing bone marrow lesions in healthy middle-aged adults without clinical knee osteoarthritis: a prospective cohort studyAn integrated mind-body approach to arthritis: a pilot study.An overview of a novel, water-soluble undenatured type II collagen (NEXT-II).Safety and toxicological evaluation of a novel, water-soluble undenatured type II collagen.Safety and toxicological evaluation of undenatured type II collagen.Levels of metals in the blood and specific porphyrins in the urine in children with autism spectrum disorders.Elucidation of dietary risk factors in osteoarthritis knee—a case-control study.
P2860
Q30512432-AF6F17E0-3608-4A75-83A5-798BB0F015A6Q33629459-3A2E009C-E40D-425C-BDD6-94FB50E67617Q34188301-C0CC1B01-F077-4632-894F-AC48A0B500D7Q35769067-8008DCC3-9560-4430-9AB8-291974EED8EFQ36084925-A1EC7F53-EEB1-419D-8BC7-3A83B1422943Q36137201-51167437-7E77-42CC-BE2F-483E808ECD04Q36469398-4B8A326B-9F57-4EE4-953F-575215339901Q36517906-E7ECAEAA-7CE4-4C63-917B-2AF97ADCCC25Q36581209-6F430583-E557-4955-B459-6D69EDA032CBQ37270750-0F2076E3-3A52-4A2C-AC15-821144AB85A9Q37730550-4E57CD46-63CF-4E1E-AC52-B128311C85AAQ38370483-FE79FC3D-F8E0-4453-92F9-79959D45F9FFQ39182757-25D88FDF-6F87-4095-977A-A18837EFE4A3Q48300377-B775D574-DD4B-4267-9B50-5530CF60A316Q50304452-690BA283-46DC-42C6-AA60-027DF685CBC1Q50446186-4E2EF55F-1069-42DD-987D-EBD9EE5054A5
P2860
Nutraceutical therapies for degenerative joint diseases: a critical review.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Nutraceutical therapies for degenerative joint diseases: a critical review.
@ast
Nutraceutical therapies for degenerative joint diseases: a critical review.
@en
type
label
Nutraceutical therapies for degenerative joint diseases: a critical review.
@ast
Nutraceutical therapies for degenerative joint diseases: a critical review.
@en
prefLabel
Nutraceutical therapies for degenerative joint diseases: a critical review.
@ast
Nutraceutical therapies for degenerative joint diseases: a critical review.
@en
P2093
P2860
P50
P1476
Nutraceutical therapies for degenerative joint diseases: a critical review
@en
P2093
Anne Vaughan-Thomas
Carolyn A Bondy
Mehdi Shakibaei
Wolfgang Schwab
P2860
P304
P356
10.1080/10408690590956341
P577
2005-01-01T00:00:00Z